Duygu B - Search Results

1

Comparison of different chemically modified inhibitors of miR-199b in vivo.

Duygu B, Juni R, Ottaviani L, Bitsch N, Wit JBM, de Windt LJ, da Costa Martins PA. Duygu B, et al. Biochem Pharmacol. 2019 Jan;159:106-115. doi: 10.1016/j.bcp.2018.11.013. Epub 2018 Nov 16. Biochem Pharmacol. 2019. PMID: 30452907 Free article.

2

Genetics and epigenetics of arrhythmia and heart failure.

Duygu B, Poels EM, da Costa Martins PA. Duygu B, et al. Front Genet. 2013 Oct 30;4:219. doi: 10.3389/fgene.2013.00219. Front Genet. 2013. PMID: 24198825 Free PMC article. Review.

3

miR-21: a star player in cardiac hypertrophy.

Duygu B, Da Costa Martins PA. Duygu B, et al. Cardiovasc Res. 2015 Mar 1;105(3):235-7. doi: 10.1093/cvr/cvv026. Epub 2015 Feb 2. Cardiovasc Res. 2015. PMID: 25644540 No abstract available.

4

Targeting microRNAs in heart failure.

Duygu B, de Windt LJ, da Costa Martins PA. Duygu B, et al. Trends Cardiovasc Med. 2016 Feb;26(2):99-110. doi: 10.1016/j.tcm.2015.05.008. Epub 2015 May 30. Trends Cardiovasc Med. 2016. PMID: 26119078 Review.

5

miR-199b-5p is a regulator of left ventricular remodeling following myocardial infarction.

Duygu B, Poels EM, Juni R, Bitsch N, Ottaviani L, Olieslagers S, de Windt LJ, da Costa Martins PA. Duygu B, et al. Noncoding RNA Res. 2017 Jan 13;2(1):18-26. doi: 10.1016/j.ncrna.2016.12.002. eCollection 2017 Mar. Noncoding RNA Res. 2017. PMID: 30159417 Free PMC article.

6

Interplay of N acetyl cysteine and melatonin in regulating oxidative stress-induced cardiac hypertrophic factors and microRNAs.

Ali T, Mushtaq I, Maryam S, Farhan A, Saba K, Jan MI, Sultan A, Anees M, Duygu B, Hamera S, Tabassum S, Javed Q, da Costa Martins PA, Murtaza I. Ali T, et al. Among authors: duygu b. Arch Biochem Biophys. 2019 Jan;661:56-65. doi: 10.1016/j.abb.2018.11.007. Epub 2018 Nov 12. Arch Biochem Biophys. 2019. PMID: 30439361

7

MicroRNA-216a is essential for cardiac angiogenesis.

Juni RP, Kocken JMM, Abreu RC, Ottaviani L, Davalan T, Duygu B, Poels EM, Vasilevich A, Hegenbarth JC, Appari M, Bitsch N, Olieslagers S, Schrijvers DM, Stoll M, Heineke J, de Boer J, de Windt LJ, da Costa Martins PA. Juni RP, et al. Among authors: duygu b. Mol Ther. 2023 Jun 7;31(6):1807-1828. doi: 10.1016/j.ymthe.2023.04.007. Epub 2023 Apr 17. Mol Ther. 2023. PMID: 37073128 Free article.

8

HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation.

Duygu B, Olieslagers TI, Groeneweg M, Voorter CEM, Wieten L. Duygu B, et al. Front Immunol. 2021 Jul 6;12:680480. doi: 10.3389/fimmu.2021.680480. eCollection 2021. Front Immunol. 2021. PMID: 34295330 Free PMC article. Review.

9

Polymorphism at residue 156 of the new HLA-A*02:683 allele suggests immunological relevance.

Duygu B, Matern BM, Groeneweg M, Voorter CEM, Tilanus MGJ. Duygu B, et al. HLA. 2017 Aug;90(2):107-109. doi: 10.1111/tan.13059. Epub 2017 May 28. HLA. 2017. PMID: 28556601

10

Long-Read Nanopore Sequencing Validated for Human Leukocyte Antigen Class I Typing in Routine Diagnostics.

Matern BM, Olieslagers TI, Groeneweg M, Duygu B, Wieten L, Tilanus MGJ, Voorter CEM. Matern BM, et al. Among authors: duygu b. J Mol Diagn. 2020 Jul;22(7):912-919. doi: 10.1016/j.jmoldx.2020.04.001. Epub 2020 Apr 14. J Mol Diagn. 2020. PMID: 32302780 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page